Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 95

Results For "ether"

1172 News Found

IQVIA launches OCE+ to deliver AI-driven customer engagement
Digitisation | March 16, 2022

IQVIA launches OCE+ to deliver AI-driven customer engagement

OCE+ uses IQVIA’s industry-leading data and advanced analytics to deliver AI-driven recommendations directly into the daily workflows of life sciences commercial teams


Srichakra receives European Food Safety approval for its food-grade recycled rPET
Sustainability | March 15, 2022

Srichakra receives European Food Safety approval for its food-grade recycled rPET

Srichakra receives European Food Safety approval for its food-grade recycled rPET


Ascletis increases ritonavir production capacity to 530 million tablets a year
Biotech | March 14, 2022

Ascletis increases ritonavir production capacity to 530 million tablets a year

Ritonavir oral tablet is a pharmacokinetic booster of multiple oral antiviral drugs targeting viral proteases and a component of the approved oral antiviral drug Paxlovid (Nirmatrelvir 300 mg tablet + ritonavir 100 mg tablet co-administration package)


Illumina welcomes Carissa Rollins as Chief Information Officer
People | March 14, 2022

Illumina welcomes Carissa Rollins as Chief Information Officer

Most recently, Rollins was the Chief Information Officer at UnitedHealthcare


Indian pharma companies must become the global benchmark of quality: Amit Jaju, Sr. MD, India, Ankura Consulting
interviews | March 13, 2022

Indian pharma companies must become the global benchmark of quality: Amit Jaju, Sr. MD, India, Ankura Consulting

Amit Jaju, Senior Managing Director, India in an interview with Thomas C Thottathil outlined the steps Indian pharma companies should follow to be compliant with global regulatory requirements


Study shows Pfizer vaccine moderately effective against Omicron for children 5-15
News | March 12, 2022

Study shows Pfizer vaccine moderately effective against Omicron for children 5-15

The study looked at 1,364 children in Arizona, Florida, Texas, and Utah who submitted weekly nasal swabs and surveys from July 2021 through February 2022, regardless of whether they had symptoms


Wipro and Pandorum partner to accelerate regenerative medicine with AI
News | March 12, 2022

Wipro and Pandorum partner to accelerate regenerative medicine with AI

Use of Wipro Holmes Artificial Intelligence capabilities will lead to faster development of advanced therapeutics, improving patient outcomes


Govt earmarks Rs 500 crore for pharma clusters and MSMEs
Policy | March 12, 2022

Govt earmarks Rs 500 crore for pharma clusters and MSMEs

Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers releases guidelines for the scheme


Cancer surgeons gather in Delhi to learn new cancer therapies
Public Health | March 11, 2022

Cancer surgeons gather in Delhi to learn new cancer therapies

Experts will speak about primary tumours of the nervous system and also the tumours of other body parts which get metastasized to the nervous system


Glaucoma is the leading cause of irreversible blindness in India: Mr. Nikkhil K Masurkar, Executive Director, Entod Pharmaceuticals
interviews | March 10, 2022

Glaucoma is the leading cause of irreversible blindness in India: Mr. Nikkhil K Masurkar, Executive Director, Entod Pharmaceuticals

As the world celebrates World Glaucoma Week (March 7-13th), Nikkhil K Masurkar, Executive Director, Entod Pharmaceuticals, an authority on eye diseases spoke to Thomas C Thottathil, Editor, indianpharmapost.com, on the seriousness of Glaucoma